It is known that while TGF-β1 released at an early stage of MI act as cardioprotective factor, presumably via the non-canonical pathway, TGF-β1 released at later time points post MI can lead to apoptosis, hypertrophy, and fibrosis. This evidence concerns the gene TGFB1 and myocardial infarction.